Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 116329
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.116329
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.116329
Table 5 Cox proportional hazards regression analysis of prognostic factors in adenoid cystic carcinoma, hazard ratio (95%CI)
| Variable | Univariate | P value | Multivariate | P value |
| Recurrence-free survival | ||||
| Advanced T stage (T3 and T4 vs T1 and T2) | 3.89 (1.21-9.85) | 0.021 | 3.46 (1.21-9.85) | 0.021 |
| Positive margins (R1/R2 vs R0) | 2.84 (1.09-7.42) | 0.032 | 2.84 (1.09-7.42) | 0.032 |
| PNI (present vs absent) | 2.67 (1.01-7.09) | 0.047 | 2.12 (0.91-6.03) | 0.081 |
| PORT (yes vs no) | 0.57 (0.24-1.31) | 0.182 | 0.57 (0.24-1.31) | 0.182 |
| Overall survival | ||||
| Advanced T stage (T3 and T4 vs T1 and T2) | 4.12 (1.39-12.20) | 0.011 | 3.28 (1.18-9.11) | 0.023 |
| Positive margins (R1/R2 vs R0) | 3.01 (1.08-8.39) | 0.035 | 2.71 (1.01-7.29) | 0.048 |
| PNI (present vs absent) | 2.74 (1.02-7.35) | 0.044 | 2.31 (0.89-6.04) | 0.075 |
| PORT (yes vs no) | 0.49 (0.21-1.12) | 0.094 | 0.52 (0.24-1.15) | 0.096 |
- Citation: Stawarz K, Gorzelnik A, Klos W, Korzon J, Kissin F, Bienkowska-Pluta K, Stawarz G, Rusetska N, Zwoliński J. Prognostic value of clinicopathological parameters in adenoid cystic carcinoma: A retrospective cohort study. World J Clin Oncol 2026; 17(4): 116329
- URL: https://www.wjgnet.com/2218-4333/full/v17/i4/116329.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i4.116329